Atossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Atossa Therapeutics

12/11/2024 15:26

* Atossa Therapeutics Inc  ATOS.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -5 cents.  The mean expectation of three analysts for the
quarter was for a loss of 6 cents per share. Wall Street
expected results to range from -6 cents to -5 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Atossa Therapeutics Inc's reported EPS for the quarter was
a
loss of 6 cents​.
    * The company reported a quarterly loss of $7.23 million.
    * Atossa Therapeutics Inc shares had risen by 6.6% this
quarter and gained 84.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Atossa
Therapeutics Inc is $6.00 
This summary was machine generated from LSEG data November 12 at
03:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.06          -0.06          Met
 Jun. 30 2024      -0.06          -0.05          Beat
 Mar. 31 2024      -0.07          -0.05          Beat
 Dec. 31 2023      -0.06          -0.09          Missed